R
RazinQ
Productby Revolution Medicines
Heard in 6 episodes across 6 shows since Aug 2026
RazinQ is identified as a cancer medicine approved for patients with metastatic pancreatic adenocarcinoma.
Discussed inMarkets100%
Episodes
6
across 6 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of RazinQ per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 26 | 0.01‰ | 1 |
| Aug 27 | 0.02‰ | 1 |
| Aug 28 | 0.03‰ | 1 |
| Sep 1 | 0.05‰ | 2 |
| Oct 30 | 0.02‰ | 2 |
| Nov 9 | 0.02‰ | 3 |
Email alert
Email me when RazinQ comes up on a podcast
One email a week at most, with the new episodes that mention RazinQ. Free, no account needed, unsubscribe in one click.
Episodes
6 episodes featuring RazinQ, newest first
- Nov 9, 2026
Biotech investors weigh obesity, RAS drugs and Moderna catalystsBreaking BiotechNov 9, 2026 - Oct 30, 2026
Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026 - Sep 1, 2026
Flood disaster and cancer breakthrough frame AM UpdateThe Megyn Kelly ShowSep 1, 2026 - Aug 28, 2026
Markets await Fed clarity as Shein cuts IPO ambitionsMorning Brew DailyAug 28, 2026 - Aug 27, 2026
Floods, political scrutiny and Tim Curry’s film legacyThe 7Aug 27, 2026 - Aug 26, 2026
Meta settlement puts teen-platform safeguards under scrutinyWSJ What’s NewsAug 26, 2026